Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Lung Neoplasms 53 Leukemia, Myeloid, Acute 52 Neoplasm Metastasis 45 Carcinoma, Non-Small-Cell Lung 40 Prostatic Neoplasms 37 Breast Neoplasms 36 Multiple Myeloma 31 Colorectal Neoplasms 29 Pancreatic Neoplasms 26 Carcinoma, Renal Cell 25 Melanoma 23 Ovarian Neoplasms 21 Myelodysplastic Syndromes 21 Triple Negative Breast Neoplasms 20 Lymphoma 20 Leukemia, Lymphocytic, Chronic, B-Cell 20 Burkitt Lymphoma 19 Lymphoma, Large B-Cell, Diffuse 18 Precursor Cell Lymphoblastic Leukemia-Lymphoma 17 Urinary Bladder Neoplasms 16 Carcinoma, Hepatocellular 16 Squamous Cell Carcinoma of Head and Neck 15 Glioblastoma 15 Fallopian Tube Neoplasms 14 Oropharyngeal Neoplasms 13 Glioma 13 Endometrial Neoplasms 13 Sarcoma 12 Mouth Neoplasms 12 Lymphoma, Non-Hodgkin 12

Interventions

Taxes 1 Specimen Handling 1 Paclitaxel 1 Magnetic Resonance Spectroscopy 1 Gemcitabine 1 Endoscopic Ultrasound-Guided Fine Needle Aspiration 1 Catheter Ablation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Pancreatic Cystic Neoplasm × Specimen Handling × 90 days × Clear all

NCT07529483 2026-05-29

ERASE-Chemo

Ohio State University Comprehensive Cancer Center

Phase 2 Recruiting

Gastrointestinal

Pancreatic Cystic Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon ⚡